393 related articles for article (PubMed ID: 2050325)
1. Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.
Crosignani A; Podda M; Bertolini E; Battezzati PM; Zuin M; Setchell KD
Hepatology; 1991 Jun; 13(6):1076-83. PubMed ID: 2050325
[TBL] [Abstract][Full Text] [Related]
2. Bile acid metabolism in benign recurrent intrahepatic cholestasis. Comparative studies on the icteric and anicteric phases of a single case.
Endo T; Uchida K; Amuro Y; Higashino K; Yamamura Y
Gastroenterology; 1979 May; 76(5 Pt 1):1002-6. PubMed ID: 437403
[TBL] [Abstract][Full Text] [Related]
3. Effects of ursodeoxycholic acid on serum liver enzymes and bile acid metabolism in chronic active hepatitis: a dose-response study.
Crosignani A; Battezzati PM; Setchell KD; Camisasca M; Bertolini E; Roda A; Zuin M; Podda M
Hepatology; 1991 Feb; 13(2):339-44. PubMed ID: 1671665
[TBL] [Abstract][Full Text] [Related]
4. Serum bile acid concentrations in the course of benign recurrent intrahepatic cholestasis.
Finni K; Similä S; Heikura S; Jänne O; Mäentausta O
Ann Clin Res; 1980 Aug; 12(4):168-71. PubMed ID: 7259083
[TBL] [Abstract][Full Text] [Related]
5. Choleretic effects of ursodeoxycholic acid on experimentally-induced intrahepatic cholestasis.
Mizoguchi Y; Miyajima K; Kioka K; Seki S; Kobayashi K; Morisawa S
Osaka City Med J; 1989 Nov; 35(2):83-91. PubMed ID: 2628845
[TBL] [Abstract][Full Text] [Related]
6. A distinctive pattern of serum bile acid and bilirubin concentrations in benign recurrent intrahepatic cholestasis.
Summerfield JA; Kirk AP; Chitranukroh A; Billing BH
Hepatogastroenterology; 1981 Jun; 28(3):139-42. PubMed ID: 7250892
[TBL] [Abstract][Full Text] [Related]
7. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
Stiehl A; Rudolph G; Sauer P; Theilmann L
J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
[TBL] [Abstract][Full Text] [Related]
8. Bile acid conjugation in early stage cholestatic liver disease before and during treatment with ursodeoxycholic acid.
Fracchia M; Setchell KD; Crosignani A; Podda M; O'Connell N; Ferraris R; Hofmann AF; Galatola G
Clin Chim Acta; 1996 Apr; 248(2):175-85. PubMed ID: 8740581
[TBL] [Abstract][Full Text] [Related]
9. Cytoprotection with ursodeoxycholic acid: effect in chronic non-cholestatic and chronic cholestatic liver disease.
Lirussi F; Okolicsanyi L
Ital J Gastroenterol; 1992 Jan; 24(1):31-5. PubMed ID: 1571577
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of ursodeoxycholic acid versus cholestyramine in intrahepatic cholestasis of pregnancy.
Kondrackiene J; Beuers U; Kupcinskas L
Gastroenterology; 2005 Sep; 129(3):894-901. PubMed ID: 16143129
[TBL] [Abstract][Full Text] [Related]
11. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.
Meng LJ; Reyes H; Axelson M; Palma J; Hernandez I; Ribalta J; Sjövall J
Hepatology; 1997 Dec; 26(6):1573-9. PubMed ID: 9398000
[TBL] [Abstract][Full Text] [Related]
12. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy.
Brites D; Rodrigues CM; Oliveira N; Cardoso M; Graça LM
J Hepatol; 1998 Jan; 28(1):91-8. PubMed ID: 9537870
[TBL] [Abstract][Full Text] [Related]
13. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy [see comemnts].
Brites D; Rodrigues CM
J Hepatol; 1998 Nov; 29(5):743-51. PubMed ID: 9833912
[TBL] [Abstract][Full Text] [Related]
14. Lithocholic acid as a biomarker of intrahepatic cholestasis of pregnancy during ursodeoxycholic acid treatment.
Lucangioli SE; Castaño G; Contin MD; Tripodi VP
Ann Clin Biochem; 2009 Jan; 46(Pt 1):44-9. PubMed ID: 19103957
[TBL] [Abstract][Full Text] [Related]
15. Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in humans.
Marschall HU; Wagner M; Zollner G; Fickert P; Diczfalusy U; Gumhold J; Silbert D; Fuchsbichler A; Benthin L; Grundström R; Gustafsson U; Sahlin S; Einarsson C; Trauner M
Gastroenterology; 2005 Aug; 129(2):476-85. PubMed ID: 16083704
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
Glantz A; Marschall HU; Lammert F; Mattsson LA
Hepatology; 2005 Dec; 42(6):1399-405. PubMed ID: 16317669
[TBL] [Abstract][Full Text] [Related]
17. Effect of maternal cholestasis on biliary lipid and bile acid secretion in the infant rat.
El-Mir MY; Monte MJ; Morales AI; Arevalo M; Serrano MA; Marin JJ
Hepatology; 1997 Sep; 26(3):527-36. PubMed ID: 9303479
[TBL] [Abstract][Full Text] [Related]
18. The biochemical and histopathological effects of ursodeoxycholic acid and metronidazole on total parenteral nutrition-associated hepatic dysfunction: an experimental study.
Günsar C; Melek M; Karaca I; Sencan A; Mir E; Ortaç R; Canan O
Hepatogastroenterology; 2002; 49(44):497-500. PubMed ID: 11995481
[TBL] [Abstract][Full Text] [Related]
19. Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration.
Crosignani A; Podda M; Battezzati PM; Bertolini E; Zuin M; Watson D; Setchell KD
Hepatology; 1991 Dec; 14(6):1000-7. PubMed ID: 1959845
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal profiles of 15 serum bile acids in patients with intrahepatic cholestasis of pregnancy.
Tribe RM; Dann AT; Kenyon AP; Seed P; Shennan AH; Mallet A
Am J Gastroenterol; 2010 Mar; 105(3):585-95. PubMed ID: 19904249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
